Flugen, Inc. Applauds Efforts to Accelerate Cell-Based Influenza Vaccine Production

MADISON, Wis.--(BUSINESS WIRE)--The following is a statement by Paul V. Radspinner, president and chief executive of Madison, Wis.-based FluGen Inc., regarding the request made of Congress yesterday by President Obama for $1.5 billion in emergency funding to combat the growing swine flu outbreak. FluGen was co-founded by Dr. Yoshihiro Kawaoka, the world-renowned influenza researcher who established the “reverse genetics” method that revolutionized influenza research.